Showing results (1981-1990 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical and Experimental Rheumatology|August 30, 2018
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)Pilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, et al.
Seminars in Arthritis and Rheumatism|September 5, 2022
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registryJurgen Sota, Antonio Vitale, Giuseppe Lopalco, et al.
Nature Reviews. Rheumatology|June 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren diseaseManuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón, et al.
JAMA Network Open|February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine TumorsSara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
Eclinicalmedicine|July 17, 2023
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort studyPilar Brito-Zerón, Alejandra Flores-Chávez, Ildiko Fanny Horváth, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2004
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyondAngelo Agostoni, Emel Aygören-Pürsün, Karen E Binkley, et al.
Rheumatology (Oxford, England)|December 25, 2019
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndromePilar Brito-Zerón, Nihan Acar-Denizli, Wan-Fai Ng, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 2, 2026
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatologyFranco Scaldaferri, Federica Di Vincenzo, Gennaro Marco Falco, et al.
RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Pageof 234